Latest SLDB reports update at 2024-03-13: 2023 ∙ 2022 ∙ 2021

Solid Biosciences SLDB

$ 10.34 0.88%

Solid Biosciences Financial Statements 2011-2024 | SLDB

Annual Financial Statements Solid Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	243 M	38.6 M	12.5 M	26.2 M	136 M	846 M	725 M	-	-	-	-	-	-
Shares	19.9 M	8.51 M	7.12 M	3.46 M	40.3 M	33.3 M	32.2 M	-	-	-	-	-	-
Historical Prices	12.2	4.53	1.75	7.58	4.45	26.8	-	-	-	-	-	-	-
Net Income	-96 M	-86 M	-72.2 M	-88.3 M	-117 M	-74.8 M	-52.1 M	-21.5 M	-6.38 M	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-104 M	-106 M	-72.3 M	-88.4 M	-119 M	-75.7 M	-54.9 M	-25.6 M	-	-	-	-	-
Interest Expense	1.1 M	-381 K	2 K	1 K	515 K	270 K	1 M	271 K	-	-	-	-	-
EBITDA	-102 M	-104 M	-69.3 M	-84.5 M	-116 M	-74.1 M	-54.4 M	-25.5 M	-6.56 M	-	-	-	-
Operating Expenses	104 M	115 M	85.9 M	88.4 M	119 M	75.7 M	-	-	-	-	-	-	-
General and Administrative Expenses	27.8 M	28.9 M	27.1 M	21.6 M	24.6 M	17.7 M	15 M	5.46 M	2.37 M	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Solid Biosciences

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	20.1 M	19.7 M	19.6 M	19.6 M	7.53 M	7.52 M	7.51 M	7.36 M	7.49 M	112 M	89.3 M	84.9 M	48.3 M	48.2 M	48.1 M	46 M	43.5 M	34.8 M	34.8 M	35.4 M	34.5 M	34.4 M	29.4 M	-	17.1 M	17 M	3.05 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-21 M	-24.6 M	-30.1 M	-	-20.4 M	-25.1 M	-25.3 M	-	-18 M	-18.7 M	-16.9 M	-	-21.2 M	-19 M	-26.7 M	-31.9 M	-29.3 M	-26.5 M	-29.6 M	-21.9 M	-19 M	-18 M	-15.9 M	-14.5 M	-53.2 M	-53.2 M	-53.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	8.09 M	6.17 M	1.92 M	-	3.54 M	3.59 M	3.34 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-23.1 M	-26.8 M	-32 M	-	-21.1 M	-25.4 M	-25.4 M	-	-18 M	-18.7 M	-16.9 M	-	-21.2 M	-19 M	-26.9 M	-32.3 M	-29.7 M	-27 M	-30.3 M	-22.4 M	-19.2 M	-18.2 M	-16 M	-15.2 M	-13.7 M	-11.9 M	-14.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	278 K	265 K	282 K	-	-13 K	-3 K	-10 K	-	-	3 K	-	-	-	1 K	1 K	-	56 K	77 K	212 K	-	38 K	118 K	31 K	-	228 K	504 K	176 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-22.5 M	-26.1 M	-31.3 M	-	-20.7 M	-24.7 M	-24.7 M	-	-17.3 M	-18 M	-16.2 M	-	-20.5 M	-17.6 M	-25.8 M	-32.3 M	-29 M	-26.3 M	-29.7 M	-22.4 M	-18.6 M	-17.9 M	-15.7 M	-15.2 M	-13.6 M	-11.8 M	-14.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	23.1 M	26.8 M	32 M	-	21.1 M	31.6 M	27.3 M	-	21.6 M	22.3 M	20.2 M	-	21.2 M	19 M	26.9 M	32.3 M	29.7 M	27 M	30.3 M	22.4 M	19.2 M	18.2 M	16 M	15.2 M	13.7 M	11.9 M	14.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	6.41 M	7.13 M	7.4 M	-	7.13 M	6.85 M	7.35 M	-	7.14 M	6.77 M	6.02 M	-	5.18 M	5.53 M	5.25 M	-	6.92 M	5.36 M	7.03 M	-	4.47 M	4.58 M	4.04 M	-	3.08 M	3.28 M	5.38 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency